Fibrinopeptide A (original) (raw)
The fibrinopeptides, fibrinopeptide A (FpA) and fibrinopeptide B (FpB), are peptides which are located in the central region of the fibrous glycoprotein fibrinogen (factor I) and are cleaved by the enzyme thrombin (factor IIa) to convert fibrinogen into covalently-linked fibrin (factor IA) monomers. The N-terminal FpA is cleaved from the Aα chains of fibrinogen and FpB from the Bβ chains of fibrinogen, with FpA released before FpB. Subsequent to their formation, fibrin monomers are converted to cross-linked fibrin polymers by the action of thrombin-activated factor XIII (fibrin stabilizing factor), and these fibrin polymers form the backbone of a thrombus (blood clot). Hence, the fibrinopeptides are sensitive markers of fibrinogenesis (fibrin generation), thrombin activity, and coagulation
| Property | Value |
|---|---|
| dbo:abstract | The fibrinopeptides, fibrinopeptide A (FpA) and fibrinopeptide B (FpB), are peptides which are located in the central region of the fibrous glycoprotein fibrinogen (factor I) and are cleaved by the enzyme thrombin (factor IIa) to convert fibrinogen into covalently-linked fibrin (factor IA) monomers. The N-terminal FpA is cleaved from the Aα chains of fibrinogen and FpB from the Bβ chains of fibrinogen, with FpA released before FpB. Subsequent to their formation, fibrin monomers are converted to cross-linked fibrin polymers by the action of thrombin-activated factor XIII (fibrin stabilizing factor), and these fibrin polymers form the backbone of a thrombus (blood clot). Hence, the fibrinopeptides are sensitive markers of fibrinogenesis (fibrin generation), thrombin activity, and coagulation. FpA is a 16-amino acid peptide. The half-life of FpA is very short at approximately 3 to 5 minutes. Hence, FpA levels provide a relatively transient measure of coagulation activation. Levels of FpA increase with age. FpA levels also gradually increase throughout pregnancy. Likewise, FpA levels have been reported to increase with estrogen therapy, including with combined birth control pills and menopausal hormone therapy, although research on FpA levels with these therapies appears to be relatively limited. (en) |
| dbo:alternativeName | Fibrinopeptide B; Fibrinopeptide B (human); FpB; FPB (en) Fibrinopeptide A; Fibrinopeptide A (human); FpA; FPA (en) |
| dbo:iupacName | (4S)-4-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-5-[[2-[[(2S)-3-carboxy-1-[[(2S)-1-[[1-[[(2S)-1-[[(2S)-4-carboxy-1-[[2-[[2-[[2-[[(2S)-1-[[(1S)-1-carboxy-4-(diaminomethylideneamino)butyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid (en) (4S)-4-(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]-4-carboxybutanoyl]amino]-5-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid (en) |
| dbo:thumbnail | wiki-commons:Special:FilePath/Fibrinopeptide_A.svg?width=300 |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 dbo:ChemicalCompound |
| rdfs:comment | The fibrinopeptides, fibrinopeptide A (FpA) and fibrinopeptide B (FpB), are peptides which are located in the central region of the fibrous glycoprotein fibrinogen (factor I) and are cleaved by the enzyme thrombin (factor IIa) to convert fibrinogen into covalently-linked fibrin (factor IA) monomers. The N-terminal FpA is cleaved from the Aα chains of fibrinogen and FpB from the Bβ chains of fibrinogen, with FpA released before FpB. Subsequent to their formation, fibrin monomers are converted to cross-linked fibrin polymers by the action of thrombin-activated factor XIII (fibrin stabilizing factor), and these fibrin polymers form the backbone of a thrombus (blood clot). Hence, the fibrinopeptides are sensitive markers of fibrinogenesis (fibrin generation), thrombin activity, and coagulation (en) |
| owl:sameAs | wikidata:Fibrinopeptide A https://global.dbpedia.org/id/GVb6x |
| foaf:depiction | wiki-commons:Special:FilePath/Fibrinopeptide_A.svg wiki-commons:Special:FilePath/Fibrinopeptide_B.svg |
| foaf:name | Fibrinopeptide A (en) Fibrinopeptide B (en) |
| is dbo:wikiPageRedirects of | dbr:FpA dbr:FpB dbr:Fibrinopeptide-A dbr:Fibrinopeptide-B dbr:Fibrinopeptide-a dbr:Fibrinopeptide-b dbr:Fibrinopeptide_A dbr:Fibrinopeptide_A_and_B dbr:Fibrinopeptide_B dbr:Fibrinopeptide_a dbr:Fibrinopeptide_b dbr:Fibrinopeptides dbr:Fibrinopeptides_A dbr:Fibrinopeptides_A_and_B dbr:Fibrinopeptides_B dbr:Fibrinopeptides_B_and_A |
| is dbo:wikiPageWikiLink of | dbr:C1orf94 dbr:Neutral_theory_of_molecular_evolution dbr:LSMEM1 dbr:KRBA1 dbr:C16orf71 dbr:C16orf90 dbr:Cerastocytin dbr:Chromosome_9_open_reading_frame_43 dbr:Lysine_carboxypeptidase dbr:Evidence_of_common_descent dbr:FpA dbr:FpB dbr:Fibrinopeptide-A dbr:Fibrinopeptide-B dbr:Fibrinopeptide-a dbr:Fibrinopeptide-b dbr:Fibrinopeptide_A dbr:Fibrinopeptide_A_and_B dbr:Fibrinopeptide_B dbr:Fibrinopeptide_a dbr:Fibrinopeptide_b dbr:Fibrinopeptides dbr:Fibrinopeptides_A dbr:Fibrinopeptides_A_and_B dbr:Fibrinopeptides_B dbr:Fibrinopeptides_B_and_A |
